Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-02-06 to 2025-02-07
Current total value of award: $9.3
Description: 4567322417!MIDAZOLAM HCL 5 MG/ML VIALML